131 related articles for article (PubMed ID: 8845375)
1. Conformational compatibility as a basis of differential affinities of tachykinins for the neurokinin-1 receptor.
Huang RR; Huang D; Strader CD; Fong TM
Biochemistry; 1995 Dec; 34(50):16467-72. PubMed ID: 8845375
[TBL] [Abstract][Full Text] [Related]
2. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
3. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
Nederpelt I; Bleeker D; Tuijt B; IJzerman AP; Heitman LH
Biochem Pharmacol; 2016 Oct; 118():88-95. PubMed ID: 27501920
[TBL] [Abstract][Full Text] [Related]
4. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.
Huang RR; Yu H; Strader CD; Fong TM
Biochemistry; 1994 Mar; 33(10):3007-13. PubMed ID: 7510519
[TBL] [Abstract][Full Text] [Related]
5. The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity.
Tian Y; Wu LH; Oxender DL; Chung FZ
J Biol Chem; 1996 Aug; 271(34):20250-7. PubMed ID: 8702757
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues involved in ligand binding to the neurokinin-2 receptor.
Huang RR; Vicario PP; Strader CD; Fong TM
Biochemistry; 1995 Aug; 34(31):10048-55. PubMed ID: 7543277
[TBL] [Abstract][Full Text] [Related]
7. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
Huang RR; Yu H; Strader CD; Fong TM
Mol Pharmacol; 1994 Apr; 45(4):690-5. PubMed ID: 8183248
[TBL] [Abstract][Full Text] [Related]
8. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
9. A mutation changes ligand selectivity and transmembrane signaling preference of the neurokinin-1 receptor.
Riitano D; Werge TM; Costa T
J Biol Chem; 1997 Mar; 272(12):7646-55. PubMed ID: 9065420
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
[TBL] [Abstract][Full Text] [Related]
11. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis.
Hastrup H; Schwartz TW
FEBS Lett; 1996 Dec; 399(3):264-6. PubMed ID: 8985159
[TBL] [Abstract][Full Text] [Related]
12. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
Brodbeck RM; Sachais BS; Krause JE
Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194
[TBL] [Abstract][Full Text] [Related]
13. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
Jensen CJ; Gerard NP; Schwartz TW; Gether U
Mol Pharmacol; 1994 Feb; 45(2):294-9. PubMed ID: 7509441
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of polar interactions and conformational compatibility to the binding of neurokinin-1 receptor antagonists.
Fong TM; Yu H; Huang RR; Cascieri MA; Swain CJ
Mol Pharmacol; 1996 Dec; 50(6):1605-11. PubMed ID: 8967983
[TBL] [Abstract][Full Text] [Related]
15. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding.
Rosenkilde MM; Cahir M; Gether U; Hjorth SA; Schwartz TW
J Biol Chem; 1994 Nov; 269(45):28160-4. PubMed ID: 7525569
[TBL] [Abstract][Full Text] [Related]
16. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
[TBL] [Abstract][Full Text] [Related]
17. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides.
Fong TM; Yu H; Huang RR; Strader CD
Biochemistry; 1992 Dec; 31(47):11806-11. PubMed ID: 1280161
[TBL] [Abstract][Full Text] [Related]
18. Conserved HisVI-17 of the NK-1 receptor is involved in binding of non-peptide antagonists but not substance P.
Zoffmann S; Gether U; Schwartz TW
FEBS Lett; 1993 Dec; 336(3):506-10. PubMed ID: 7506676
[TBL] [Abstract][Full Text] [Related]
19. Identification of an epitope in the substance P receptor important for recognition of the common carboxyl-terminal tachykinin sequence.
Werge TM
J Biol Chem; 1994 Sep; 269(35):22054-8. PubMed ID: 7520910
[TBL] [Abstract][Full Text] [Related]
20. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
